Trial Profile
Clinical Trials Insight: 700030324
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Feb 2008
Price :
$35
*
At a glance
- Drugs SF 1019 (Primary)
- Indications Diabetic foot ulcer
- Focus Adverse reactions
- Sponsors Argyll Biotechnologies
- 04 Feb 2008 New trial record.